Coming November 4: ASH publishes its abstracts and its oral and poster sessions. We’ll add the institutions presenting them as they become publicly available.

Enliven Therapeutics at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Enliven Therapeutics exhibits at Booth 557 at ASH 2026 in New Orleans. Enliven Therapeutics supports a symposium on chronic myeloid leukemia across the whole course of treatment. It covers choosing therapy, tracking response with molecular monitoring and protecting quality of life over the long term.

OrganizationASH 2026 Attendance
enliventherapeutics.com
Biotech
Clinical-stage precision oncology company developing kinase inhibitors, including ELVN-001 for chronic myeloid leukemia.
Booth
Exhibiting at Booth 557
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
11:00am–2:00pm
CML Treatment Continuum: Optimizing Therapy Selection, Molecular Monitoring, And Long-Term Quality of Life
First-line drug choice, resistance, long-term side effects, and treatment-free remission in chronic myeloid leukemia, plus pipeline agents.
Convention Center · Great Hall BC
Leukemias

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Enliven Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction